Cerritos, CALIFORNIA5 Active Studies

Lung Cancer Clinical Trials in Cerritos, CALIFORNIA

Find 5 actively recruiting lung cancer clinical trials in Cerritos, CALIFORNIA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
4,337
Enrolling

Recruiting Lung Cancer Studies in Cerritos

RecruitingCerritos, CALIFORNIANCT05899608

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

This is a Phase 3 Randomized, double-blind, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non...

1,080 participants
Summit Therapeutics
View Study Details
RecruitingCerritos, CALIFORNIANCT05800015

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

This study is researching an investigational drug called fianlimab (also called REGN3767) with two other medications called cemiplimab and chemotherapy, individually called a "study drug" or collectiv...

950 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingCerritos, CALIFORNIANCT06311721

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®)....

927 participants
Amgen
View Study Details
RecruitingCerritos, CALIFORNIANCT06767514

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival....

780 participants
Summit Therapeutics
View Study Details
RecruitingCerritos, CALIFORNIANCT05671510

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who h...

600 participants
OncoC4, Inc.
View Study Details

About Lung Cancer Clinical Trials in Cerritos

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Cerritos, CALIFORNIA. These studies are seeking a combined 4,337 participants. Research is being sponsored by Summit Therapeutics, Regeneron Pharmaceuticals, Amgen and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Cerritos — FAQ

Are there lung cancer clinical trials in Cerritos?

Yes, there are 5 lung cancer clinical trials currently recruiting in Cerritos, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cerritos?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cerritos research site will contact you about next steps.

Are clinical trials in Cerritos free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cerritos studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Cerritos are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov